Systematic Review of Blood Biomarkers for Alzheimer’s Disease Onset and Progression (Journal of Alzheimer’s Disease)

Summary

Blood-based protein biomarkers to predict the onset and progression of Alzheimer’s Disease (AD) would assist in timely diagnosis and would also be beneficial for clinical trials in helping with the selection of subjects for preventative trials. This systematic review considers 163 candidate biomarkers. Four candidate biomarkers appear to be AD-related: α-1-antitrypsin, α-2-macroglobulin, apolipoprotein E, and complement C3. A large-scale replication study has been performed on 94 of the 163 candidate biomarkers..

Full Text Link

Reference

Kiddle, SJ. Sattlecker, M. Proitsi, P. [et al] (2014). Candidate blood proteome markers of Alzheimer’s Disease onset and progression: a systematic review and replication study. Journal of Alzheimer’s Disease: JAD. 2014; 38(3): 515-31. (Click here to view the PubMed abstract).

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Diagnosis, For Doctors (mostly), For Researchers (mostly), International, Systematic Reviews, UK and tagged , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.